Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lorenzo Trippa, Ph.D.

Co-Author

This page shows the publications co-authored by Lorenzo Trippa and Rifaquat Rahman.
Connection Strength

2.648
  1. Leveraging external data in the design and analysis of clinical trials in neuro-oncology. Lancet Oncol. 2021 10; 22(10):e456-e465.
    View in: PubMed
    Score: 0.962
  2. The use of external control data for predictions and futility interim analyses in clinical trials. Neuro Oncol. 2022 02 01; 24(2):247-256.
    View in: PubMed
    Score: 0.246
  3. KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials. Database (Oxford). 2021 06 26; 2021.
    View in: PubMed
    Score: 0.236
  4. Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials. JAMA Netw Open. 2021 03 01; 4(3):e213304.
    View in: PubMed
    Score: 0.231
  5. The effects of releasing early results from ongoing clinical trials. Nat Commun. 2021 02 05; 12(1):801.
    View in: PubMed
    Score: 0.230
  6. Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide. Int J Radiat Oncol Biol Phys. 2020 11 01; 108(3):716-724.
    View in: PubMed
    Score: 0.218
  7. A Quantitative Framework for Modeling COVID-19 Risk During Adjuvant Therapy Using Published Randomized Trials of Glioblastoma in the Elderly. Neuro Oncol. 2020 Apr 27.
    View in: PubMed
    Score: 0.218
  8. Deviation from the Proportional Hazards Assumption in Randomized Phase 3 Clinical Trials in Oncology: Prevalence, Associated Factors, and Implications. Clin Cancer Res. 2019 11 01; 25(21):6339-6345.
    View in: PubMed
    Score: 0.207
  9. To randomize, or not to randomize, that is the question: using data from prior clinical trials to guide future designs. Neuro Oncol. 2019 10 09; 21(10):1239-1249.
    View in: PubMed
    Score: 0.052
  10. The clinical trials landscape for glioblastoma: is it adequate to develop new treatments? Neuro Oncol. 2018 07 05; 20(8):1034-1043.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.